Richard B Rosen1, Jorge S Andrade Romo2, Brian D Krawitz3, Shelley Mo3, Amani A Fawzi4, Rachel E Linderman5, Joseph Carroll6, Alexander Pinhas7, Toco Y P Chui3. 1. Icahn School of Medicine at Mount Sinai, New York, New York, USA; Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. Electronic address: rrosen@nyee.edu. 2. Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. 3. Icahn School of Medicine at Mount Sinai, New York, New York, USA; Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. 4. Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. 5. Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. 6. Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA. 7. Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA; Ophthalmology, State University of New York Downstate Medical Center, New York, New York, USA.
Abstract
PURPOSE: To compare perfused capillary density (PCD) in diabetic patients and healthy controls using optical coherence tomography angiography (OCTA). METHODS: Forty controls, 36 diabetic subjects without clinical retinopathy (NoDR), 38 with nonproliferative retinopathy (NPDR), and 38 with proliferative retinopathy (PDR) were imaged using spectral-domain optical coherence tomography. A 3 × 3-mm full-thickness parafoveal OCTA scan was obtained from each participant. Following manual delineation of the foveal avascular zone (FAZ), FAZ area, perimeter, and acircularity index were determined. Seven consecutive equidistant 200-μm-wide annular segments were drawn at increasing eccentricities from the FAZ margin. Annular PCD (%) was defined as perfused capillary area divided by the corresponding annulus area after subtraction of noncapillary blood vessel areas. Nonparametric Kruskal-Wallis testing with Bonferroni correction was performed in pairwise comparisons of group PCD values. RESULTS: The NoDR group demonstrated consistently higher PCD compared to the control group in all 7 annuli, reaching statistical significance (36.6% ± 3.30% vs 33.6% ± 3.98%, P = .034) at the innermost annulus (FAZ margin to 200 μm out). The NPDR and PDR groups demonstrated progressively decreasing PCD. Differences in FAZ metrics between the NoDR and control groups did not reach statistical significance. CONCLUSIONS: Relative to healthy controls, increased PCD values in the NoDR group likely represent an autoregulatory response to increased metabolic demand, while the decrease in PCD that follows in NPDR and PDR results largely from an incremental loss of capillary segments. These findings, consistent with previous studies, demonstrate the potential of OCTA as a clinical tool for earlier objective detection of preclinical diabetic retinopathy. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
PURPOSE: To compare perfused capillary density (PCD) in diabeticpatients and healthy controls using optical coherence tomography angiography (OCTA). METHODS: Forty controls, 36 diabetic subjects without clinical retinopathy (NoDR), 38 with nonproliferative retinopathy (NPDR), and 38 with proliferative retinopathy (PDR) were imaged using spectral-domain optical coherence tomography. A 3 × 3-mm full-thickness parafoveal OCTA scan was obtained from each participant. Following manual delineation of the foveal avascular zone (FAZ), FAZ area, perimeter, and acircularity index were determined. Seven consecutive equidistant 200-μm-wide annular segments were drawn at increasing eccentricities from the FAZ margin. Annular PCD (%) was defined as perfused capillary area divided by the corresponding annulus area after subtraction of noncapillary blood vessel areas. Nonparametric Kruskal-Wallis testing with Bonferroni correction was performed in pairwise comparisons of group PCD values. RESULTS: The NoDR group demonstrated consistently higher PCD compared to the control group in all 7 annuli, reaching statistical significance (36.6% ± 3.30% vs 33.6% ± 3.98%, P = .034) at the innermost annulus (FAZ margin to 200 μm out). The NPDR and PDR groups demonstrated progressively decreasing PCD. Differences in FAZ metrics between the NoDR and control groups did not reach statistical significance. CONCLUSIONS: Relative to healthy controls, increased PCD values in the NoDR group likely represent an autoregulatory response to increased metabolic demand, while the decrease in PCD that follows in NPDR and PDR results largely from an incremental loss of capillary segments. These findings, consistent with previous studies, demonstrate the potential of OCTA as a clinical tool for earlier objective detection of preclinical diabetic retinopathy. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
Authors: Mara Lorenzi; Gilbert T Feke; Linda Pitler; Fatmire Berisha; Julia Kolodjaschna; J Wallace McMeel Journal: Invest Ophthalmol Vis Sci Date: 2010-06-30 Impact factor: 4.799
Authors: A Luksch; K Polak; B Matulla; S Dallinger; S Kapiotis; G Rainer; M Wolzt; L Schmetterer Journal: Diabetologia Date: 2001-01 Impact factor: 10.122
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2019-03-01 Impact factor: 4.799
Authors: Ian C Holmen; Sri Meghana Konda; Jeong W Pak; Kyle W McDaniel; Barbara Blodi; Kimberly E Stepien; Amitha Domalpally Journal: JAMA Ophthalmol Date: 2020-02-01 Impact factor: 7.389
Authors: Jing Yan Yang; Qian Wang; Yan Ni Yan; Wen Jia Zhou; Ya Xing Wang; Shou Ling Wu; Ming Xia Yuan; Wen Bin Wei; Jost B Jonas Journal: Graefes Arch Clin Exp Ophthalmol Date: 2020-01-02 Impact factor: 3.117
Authors: Alon Harris; Giovanna Guidoboni; Brent Siesky; Sunu Mathew; Alice C Verticchio Vercellin; Lucas Rowe; Julia Arciero Journal: Prog Retin Eye Res Date: 2020-01-24 Impact factor: 21.198
Authors: Tristan T Hormel; Thomas S Hwang; Steven T Bailey; David J Wilson; David Huang; Yali Jia Journal: Prog Retin Eye Res Date: 2021-03-22 Impact factor: 21.198